SMALL CAP SIREN

Monday, November 2, 2026

SEC distress filings for November 2, 2026: Neumora Therapeutics, Annovis Bio, Bridger Aerospace Group Holdings

Three filings from small caps that hit EDGAR on October 30, 2026, each with one factual line and a link to the source. Summaries of public SEC filings, not investment advice. Always read the filing.

  1. Neumora Therapeutics, Inc. ($NMRA)
    Bid-price deficiency notice (8-K Item 3.01) · 8-K filed Oct 30, 2026

    Neumora Therapeutics says it received a Nasdaq notice on October 26, 2026 that it does not meet the $1.00 minimum bid price requirement; it has a period of 180 calendar days, or until April 26, 2027, to regain compliance.

    Read the filing on sec.gov →
  2. Annovis Bio, Inc. ($ANVS)
    Listing deficiency notice (8-K Item 3.01) · 8-K filed Oct 30, 2026

    Annovis Bio says it received a NYSE notice on October 29, 2026 that it does not meet the stockholders' equity requirement.

    Read the filing on sec.gov →
  3. Bridger Aerospace Group Holdings, Inc. ($BAER)
    Bid-price deficiency notice (8-K Item 3.01) · 8-K filed Oct 30, 2026

    Bridger Aerospace Group Holdings says it received a Nasdaq notice on October 28, 2026 that it does not meet the $1.00 minimum bid price requirement; it has until April 26, 2027 to regain compliance.

    Read the filing on sec.gov →
Get the full list free, every weekday at 7 AM ET

Today's full issue flagged 19 filings: auditor changes, restatements, delisting notices, bankruptcies and going-concern language, each linked to EDGAR. It's free, one email each weekday.

Unsubscribe anytime in one click. Not investment advice. See a sample issue →

← Previous day · All daily top 3s